Schonfeld Strategic Advisors LLC
Position in ALDX — Aldeyra Therapeutics, Inc.
CIK 1665241
NEW YORK, NY
Position in ALDX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$44,559
-$319,305 QoQ
Shares Held
20,920
-42.9% QoQ
Ownership
0.035%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#68
of 108 holders
Holding Since
Jun 2020
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ALDX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Schonfeld Strategic Advisors LLC holds $420,669,608 across 133 Biotechnology names. ALDX ranks #126 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INBX |
Inhibrx Biosciences, Inc.
|
697,586 | $66,096,273 | |
| 2 | AGIO |
Agios Pharmaceuticals, Inc.
|
520,083 | $19,300,280 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
77,272 | $18,620,233 | |
| 4 | VRDN |
Viridian Therapeutics, Inc.\DE
|
793,508 | $14,576,741 | |
| 5 | MBX |
MBX Biosciences, Inc.
|
248,670 | $13,726,584 | |
| 6 | XENE |
Xenon Pharmaceuticals Inc.
|
227,330 | $13,721,638 | |
| 7 | PTCT |
Ptc Therapeutics, Inc.
|
147,425 | $12,025,457 | |
| 8 | INSM |
INSMED Inc
|
104,378 | $11,128,782 |
All Filings in ALDX
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $44,559 | 20,920 | Shares | Sole | 2026-08-14 | |
| 2023-03-31 | $363,864 | 36,643 | Shares | Sole | 2023-05-15 | |
| 2021-09-30 | $252,864 | 28,800 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $351,162 | 30,994 | Shares | Sole | 2021-11-16 | |
| 2021-03-31 | $183,023 | 15,406 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $230,866 | 33,654 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $801,021 | 108,100 | Shares | Sole | 2020-11-19 | |
| 2020-06-30 | $573,792 | 137,600 | Shares | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||